Has Brian McManus, MD received payments from drug or device companies?

Yes. Drug and device makers reported $7,884 in general payments to Brian McManus, MD across 176 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Brian McManus, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Brian McManus, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Brian McManus, MD

Otolaryngology · Slidell, LANPI 1477089233

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,364 of the $7,884 with a category attached, or 68.0%. 23 manufacturers reported payments, led by Inspire Medical Systems, Inc. at 25.2% of the total. Reporting peaked in 2023 at $4,356 and has fallen 64.8% since, to $1,534 in 2025. Among otolaryngology clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,884in general payments, 2019–2025

Across 176 payments — averaging $44.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Inspire Medical Systems, Inc.$2K
Medtronic$1K
Acclarent, Inc$926
Aerin Medical Inc.$860
GSK$627
Sanofi$313
plus $2K from 17 others

What the payments were for

Travel & lodging$2,33530%
Food & beverage$5,36468%
Education$1862%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Inspire Medical Systems, Inc.	30	$1,989
Medtronic	12	$1,495
Acclarent, Inc	18	$926
Aerin Medical Inc.	13	$860
GSK	32	$627
Sanofi	13	$313
Regeneron Healthcare Solutions, Inc.	16	$306
Intersect ENT, Inc.	3	$287
Integra Lifesciences Corporation	6	$187
Optinose US, Inc.	10	$174
Sanofi-aventis U.S. LLC	2	$152
Bayer	1	$131
Stryker	3	$99
Hikma Pharmaceuticals USA	5	$88
Smith+Nephew	3	$55
Amgen	2	$55
Itamar Medical Inc	1	$29
Phadia US Inc.	1	$20
Paratek Pharmaceuticals, Inc.	1	$19
Baxter Healthcare	1	$18
Merck	1	$18
Lilly USA, LLC	1	$18
Olympus America Inc.	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,884 in reported general payments places this provider in the 90th percentile of 218 otolaryngology providers in Louisiana.

See all otolaryngology providers in Louisiana →

Medicare billing

Part B allowed, 2024

$59,034

Medicare patients

231

Services billed

708

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ipratropium Bromide	152	$3,259
Fluticasone Propionate	133	$1,767
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth	17	$1,680
Fluocinolone Acetonide Oil	25	$1,340
Azelastine Hcl	58	$1,318
Famotidine	74	$858
Mupirocin	35	$244
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	23	$237
Methylprednisolone	29	$207
Pantoprazole Sodium	14	$137
Doxycycline Monohydrate	11	$130
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	14	$90
Ondansetron OdtOndansetron	20	$80
Amoxicillin	12	$34

Paid to pharmacies, not to this prescriber.